logo RPQure v6 flattened v2

logo RPQure banner 2

group 2020 spring

News on AMD drug (2)

Roche has announced that phase III clinical studies have been initiated for lampalizumab, an investigational drug for geographic atrophy (GA), the advanced form of age-related macular degeneration (AMD).

Read more: News on AMD drug (2)

New RPQure website

The new RPQure Neuromedical Genetics website is up and running to inform about progress in retinal gene therapy, especially on retinitis pigmentosa and Leber congenital amaurosis due to mutations in the CRB1 gene.

Continue reading:New RPQure website